case_images: PMC4439491_01
case_images: Fundus photo revealed the presence of a choroidal yellow-white elevated lesion, superior-nasal to the disc, with an orange pigmentation on its surface.
case_images: CRIOPM2015-142408.001.jpg
case_images: PMC4439491_01_CRIOPM2015-142408.001.jpg
case_images: fig1
case_images: Her fundus exam revealed in the left eye a choroidal yellow-white elevated lesion, nasal to the optic nerve, with an orange pigmentation on its surface (Figure 1).
case_images: At diagnosis, B-scan ultrasound showed an elevated choroidal lesion with moderate internal reflectivity in the left eye.
case_images: CRIOPM2015-142408.002.jpg
case_images: PMC4439491_01_CRIOPM2015-142408.002.jpg
case_images: fig2
case_images: A B-scan ultrasound revealed a dome-shaped elevated choroidal lesion with moderate internal reflectivity of 1.5 mm height (Figure 2).
case_images: At diagnosis, optical coherence tomography of the left eye demonstrated a dome-shaped elevation of both the neurosensory retina and retinal pigment epithelium- (RPE-) Bruch reflectivity associated with subretinal fluid.
case_images: CRIOPM2015-142408.003.jpg
case_images: PMC4439491_01_CRIOPM2015-142408.003.jpg
case_images: fig3
case_images: Spectral-domain optical coherence tomography (SD-OCT) demonstrated a dome-shaped elevation of both the neurosensory retina and retinal pigment epithelium- (RPE-) Bruch reflectivity associated with subretinal fluid, in addition to a thickening of the RPE-Bruch reflectivity overlying the choroidal elevation in the left eye (Figure 3).
case_images: Fundus photo showed a decrease in the height of the choroidal lesion after 4 cycles of chemotherapy and intravenous bevacizumab.
case_images: CRIOPM2015-142408.004.jpg
case_images: PMC4439491_01_CRIOPM2015-142408.004.jpg
case_images: fig4
case_images: After 4 cycles, lung primary cancer decreased to 9 mm and ophthalmologic examination showed complete regression of the choroidal lesion and complete resolution of the fluid, as demonstrated by the B-scan and the SD-OCT (Figures 4, 5, and 6).
case_images: B-scan ultrasound showed a complete regression of the choroidal lesion after 4 cycles of chemotherapy and intravenous bevacizumab.
case_images: CRIOPM2015-142408.005.jpg
case_images: PMC4439491_01_CRIOPM2015-142408.005.jpg
case_images: fig5
case_images: After 4 cycles, lung primary cancer decreased to 9 mm and ophthalmologic examination showed complete regression of the choroidal lesion and complete resolution of the fluid, as demonstrated by the B-scan and the SD-OCT (Figures 4, 5, and 6).
case_images: Optical coherence tomography of the left eye showed a complete resolution of the subretinal fluid after 4 cycles of chemotherapy and intravenous bevacizumab.
case_images: CRIOPM2015-142408.006.jpg
case_images: PMC4439491_01_CRIOPM2015-142408.006.jpg
case_images: fig6
case_images: After 4 cycles, lung primary cancer decreased to 9 mm and ophthalmologic examination showed complete regression of the choroidal lesion and complete resolution of the fluid, as demonstrated by the B-scan and the SD-OCT (Figures 4, 5, and 6).